Insider Transactions in Q3 2023 at Olema Pharmaceuticals, Inc. (OLMA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
25,000
-2.5%
|
$300,000
$12.41 P/Share
|
|
Sep 19
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
20,000
-3.38%
|
$240,000
$12.67 P/Share
|
|
Sep 14
2023
|
Bvf Partners L P Director |
BUY
Other acquisition or disposition
|
Indirect |
99,556
+50.0%
|
-
|
|
Sep 12
2023
|
G. Walmsley Graham Director |
BUY
Open market or private purchase
|
Indirect |
508,130
+23.35%
|
$4,573,170
$9.84 P/Share
|
|
Sep 12
2023
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
1,505,932
+13.08%
|
$13,553,388
$9.84 P/Share
|
|
Sep 05
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
10,000
-0.99%
|
$110,000
$11.62 P/Share
|
|
Aug 31
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.47%
|
$135,000
$9.36 P/Share
|
|
Aug 16
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.44%
|
$150,000
$10.14 P/Share
|